Search and Browse
Download
Enter Data
| Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311805 (7-(4-Fluorophenyl)-8-(7-chloro-1H-indazol-5-yl)-2-...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet  | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.0100 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311771 (2-Cyclopentyl-7-(4-fluorophenyl)-8-(7-methyl-1H-in...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.0160 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311848 (8-(7-Chloro-1H-indazol-5-yl)-2-isopropyl-7-(triflu...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.0250 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311766 (2-Cyclobutyl-7-(4-fluorophenyl)-8-(7-methyl-1H-ind...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.0250 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311811 (7-Isopropyl-8-(7-methyl-1H-indazol-5-yl)-2-(triflu...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.0320 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311806 (7-(4-Fluorophenyl)-8-(7-methyl-1H-indazol-5-yl)-2-...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.0320 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311808 (2-(Difluoromethyl)-7-(4-fluorophenyl)-8-(7-methyl-...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.0320 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311847 (5-(2,7-Bis(trifluoromethyl)imidazo[1,2-a]pyridin-8...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.0500 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311768 (7-Cyclopentyl-8-(7-methyl-1H-indazol-5-yl)-2-(trif...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.0790 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311810 (2-Cyclopropyl-7-(4-fluorophenyl)-8-(7-methyl-1H-in...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.0790 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311828 (8-(7-Chloro-1H-indazol-5-yl)-2-isopropyl-7-(triflu...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.100 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311849 (2-Isopropyl-8-(7-methyl-1H-indazol-5-yl)-7-(triflu...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.100 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311829 (8-(7-Chloro-1H-indazol-5-yl)-2-cyclopropyl-7-(trif...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.126 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311843 (3-Chloro-8-(7-chloro-1H-indazol-5-yl)-2-cyclopropy...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.126 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311799 (8-(7-Chloro-1H-indazol-5-yl)-2-isopropyl-7-(triflu...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.126 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311845 (5-(2,7-Bis(trifluoromethyl)imidazo[1,2-a]pyridin-8...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.158 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311792 (8-(7-Chloro-1H-indazol-5-yl)-2-cyclopropyl-7-(trif...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.158 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311833 (8-(7-Chloro-1H-indazol-5-yl)-7-isopropyl-2-(triflu...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.158 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311793 (2-Cyclopropyl-8-(7-methyl-1H-indazol-5-yl)-7-(trif...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.200 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311850 (2-Cyclopropyl-8-(7-methyl-1H-indazol-5-yl)-7-(trif...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.251 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311830 (2-Cyclopropyl-8-(7-methyl-1H-indazol-5-yl)-7-(trif...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.251 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311781 (8-(7-Chloro-1H-indazol-5-yl)-2,7-bis(trifluorometh...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.251 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311767 (6-(7-(4-Fluorophenyl)-2-(trifluoromethyl)-[1,2,4]t...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.251 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311831 (7-Chloro-5-[2-cyclopropyl-7-(trifluoromethyl)imida...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.316 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311783 (5-(2,7-Bis(trifluoromethyl)-[1,2,4]triazolo[1,5-a]...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.316 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311769 (7-(Azetidin-1-yl)-8-(7-methyl-1H-indazol-5-yl)-2-(...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.316 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311834 (8-(7-Chloro-1H-indazol-5-yl)-2-(difluoromethyl)-7-...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.316 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311824 (5-(2,7-Bis(trifluoromethyl)imidazo[1,2-a]pyridin-8...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.316 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311844 (8-(7-Chloro-1H-indazol-5-yl)-2-cyclopropyl-3-fluor...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.316 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311754 (8-(7-Chloro-1H-indazol-5-yl)-2-(difluoromethyl)-7-...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.316 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311775 (8-(7-Chloro-1H-indazol-5-yl)-2,7-bis(trifluorometh...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.316 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311785 (8-(7-Chloro-1H-indazol-5-yl)-7-(difluoromethyl)-2-...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.398 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311846 (5-(2,7-Bis(trifluoromethyl)imidazo[1,2-a]pyridin-8...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.398 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311796 (8-(7-Chloro-1H-indazol-5-yl)-2-ethyl-7-(trifluorom...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.398 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311776 (8-(7-Chloro-1H-indazol-5-yl)-2-(difluoromethyl)-7-...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.398 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311851 (2-Ethyl-8-(7-methyl-1H-indazol-5-yl)-7-(trifluorom...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.398 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311826 (8-(7-Chloro-1H-indazol-5-yl)-2-ethyl-7-(trifluorom...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.501 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311852 (2-(Difluoromethyl)-8-(7-methyl-1H-indazol-5-yl)-7-...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.501 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311782 (8-(7-Methyl-1H-indazol-5-yl)-2,7-bis(trifluorometh...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.501 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311787 (7-Chloro-5-(7-(difluoromethyl)-2-(trifluoromethyl)...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.631 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311842 (8-(7-Chloro-1H-indazol-5-yl)-7-cyclopropyl-2-(difl...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.631 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311786 (8-(7-Methyl-1H-indazol-5-yl)-7-(difluoromethyl)-2-...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.631 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311801 (5-[2-Isopropyl-7-(trifluoromethyl)-[1,2,4]triazolo...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.631 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311790 (7-Ethyl-8-(7-methyl-1H-indazol-5-yl)-2-(trifluorom...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.794 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311784 (5-(2,7-Bis(trifluoromethyl)-[1,2,4]triazolo[1,5-a]...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.794 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311835 (8-(7-Chloro-1H-indazol-5-yl)-7-ethyl-2-(trifluorom...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.794 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311778 (8-(7-Methyl-1H-indazol-5-yl)-2-(difluoromethyl)-7-...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311773 (7-Methyl-5-[7-methyl-2-(trifluoromethyl)imidazo[1,...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311839 (8-(7-Chloro-1H-indazol-5-yl)-7-cyclopropyl-2-(trif...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311803 (7-Chloro-8-(7-chloro-1H-indazol-5-yl)-2-(trifluoro...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311804 (7-(4-Fluorophenyl)-8-(7-fluoro-1H-indazol-5-yl)-2-...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311788 (7-Methyl-5-(7-(difluoromethyl)-2-(trifluoromethyl)...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311822 (7-Chloro-8-(7-methyl-1H-indazol-5-yl)-2-(trifluoro...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311825 (8-(7-Methyl-1H-indazol-5-yl)-2,7-bis(trifluorometh...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.26 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311837 (8-(7-Chloro-1H-indazol-5-yl)-2-(difluoromethyl)-7-...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.26 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311779 (7-Chloro-5-(2-(difluoromethyl)-7-(trifluoromethyl)...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.26 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311841 (8-(7-Chloro-1H-indazol-5-yl)-7-cyclopropyl-5-methy...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.26 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311797 (2-Ethyl-8-(7-methyl-1H-indazol-5-yl)-7-(trifluorom...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.58 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311827 (2-Ethyl-8-(7-methyl-1H-indazol-5-yl)-7-(trifluorom...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.58 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311798 (5-[2-Ethyl-7-(trifluoromethyl)-[1,2,4]triazolo[1,5...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311836 (7-Ethyl-8-(7-methyl-1H-indazol-5-yl)-2-(trifluorom...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311809 (7-(4-Fluorophenyl)-2-(methoxymethyl)-8-(7-methyl-1...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311777 (2-(Difluoromethyl)-8-(7-methyl-1H-indazol-5-yl)-7-...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311800 (2-Isopropyl-8-(7-methyl-1H-indazol-5-yl)-7-(triflu...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311770 (7-(3-Fluoroazetidin-1-yl)-8-(7-methyl-1H-indazol-5...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.51 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311840 (8-(7-Chloro-1H-indazol-5-yl)-7-cyclopropyl-2-(difl...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.51 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311780 (7-Methyl-5-(2-(difluoromethyl)-7-(trifluoromethyl)...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.51 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311838 (8-(7-Chloro-1H-indazol-5-yl)-7-methyl-2-(trifluoro...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.16 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311764 (7-Chloro-8-(7-methyl-1H-indazol-5-yl)-2-(trifluoro...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.16 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311774 (5-(7-(4-Fluorophenyl)-2-(trifluoromethyl)imidazo[1...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.16 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311789 (7-Methyl-8-(7-methyl-1H-indazol-5-yl)-2-(trifluoro...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.98 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311794 (8-(7-Chloro-1H-indazol-5-yl)-2-methyl-7-(trifluoro...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.01 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311821 (7-Methoxy-8-(7-methyl-1H-indazol-5-yl)-2-(trifluor...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 7.94 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311765 (6-(2,7-Bis(trifluoromethyl)-[1,2,4]triazolo[1,5-a]...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 7.94 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311853 (2-Methyl-8-(7-methyl-1H-indazol-5-yl)-7-(trifluoro...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 7.94 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311814 (7-Methyl-8-(7-methyl-1H-indazol-5-yl)-2-(trifluoro...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 10 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311795 (2-Methyl-8-(7-methyl-1H-indazol-5-yl)-7-(trifluoro...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 12.6 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311818 (7-Methyl-8-(7-methyl-1H-indazol-5-yl)-2-phenyl-imi...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 12.6 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311820 (5-[7-Methoxy-2-(trifluoromethyl)imidazo[1,2-a]pyri...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 15.8 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311772 (8-(7-Methyl-1H-indazol-5-yl)-2-(trifluoromethyl)-[...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 20 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311807 (8-(3-Fluoro-1H-indazol-5-yl)-7-(4-fluorophenyl)-2-...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 25.1 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311819 (2-Cyclopropyl-7-methyl-8-(7-methyl-1H-indazol-5-yl...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 25.1 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311791 (7-Methoxy-8-(7-methyl-1H-indazol-5-yl)-2-(trifluor...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 25.1 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311815 (2-tert-Butyl-7-methyl-8-(7-methyl-1H-indazol-5-yl)...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 31.6 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311823 (5-(2,7-Bis(trifluoromethyl)imidazo[1,2-a]pyridin-8...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 31.6 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311817 (7-Methyl-5-(7-methyl-2-phenyl-imidazo[1,2-a]pyridi...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 39.8 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311813 (7-Fluoro-5-[7-methyl-2-(trifluoromethyl)imidazo[1,...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 63.1 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311812 (8-(1H-Indazol-5-yl)-7-methyl-2-(trifluoromethyl)im...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 63.1 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311816 (5-(2-tert-Butyl-7-methyl-imidazo[1,2-a]pyridin-8-y...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 79.4 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311802 (2-Isopropyl-7-methyl-8-(7-methyl-1H-indazol-5-yl)-...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 126 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM311832 (5-[2-Cyclopropyl-7-(trifluoromethyl)imidazo[1,2-c]...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.01E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description An in vitro assay was used to determine the potency of test compounds as inhibitors of the glutamate response of the channel formed by GluA1o-γ8... | US Patent US10155769 (2018) BindingDB Entry DOI: 10.7270/Q2SB47TC | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
